IL6 and neoplasm: While a very recent study reported that cachexia in PDAC is mediated by trans-signaling of tumor-derived IL-6 among tumor, muscle and fat tissue [30], others showed that circulating IL-6 levels correlate rather with advanced disease stage but less with weight loss and cachexia in PDAC patients [31].